Survival Rates High for Children, Teens With Melanoma
TUESDAY, Jan. 10, 2023 (HealthDay News) — Survival rates for children and adolescents with melanomas are high, according to a study published online Dec. 9 in the Journal of the American Academy of Dermatology.Mary-Ann El Sharouni, Ph.D., from the Un…
Learn MoreModerna y Merck reportan sobre una promisoria vacuna contra el melanoma
MARTES, 13 de diciembre de 2022 (HealthDay News) — Dos compañías farmacéuticas dijeron el martes que han logrado notables avances con una vacuna que podría prevenir el melanoma.Moderna, famosa por su trabajo en la vacuna contra la COVID, y Merck, que…
Learn MoreModerna, Merck Report on Promising Melanoma Vaccine
TUESDAY, Dec. 13, 2022 (HealthDay News) — Two pharmaceutical companies said Tuesday that they have made notable progress with a vaccine that could prevent melanoma.Moderna, well known for its work on the COVID-19 vaccine, and Merck, which makes the c…
Learn MoreModerna, Merck Report on Promising Melanoma Vaccine
TUESDAY, Dec. 13, 2022 (HealthDay News) — Two pharmaceutical companies said Tuesday that they have made notable progress with a vaccine that could prevent melanoma. Moderna, well known for its work on the COVID vaccine, and Merck, which makes the can…
Learn MoreTumor-Infiltrating Lymphocytes Up PFS in Advanced Melanoma
THURSDAY, Dec. 8, 2022 (HealthDay News) — For patients with advanced melanoma, infusion of tumor-infiltrating lymphocytes (TIL) is associated with significantly longer progression-free survival than ipilimumab treatment, according to a study publishe…
Learn MoreMelanoma Patients Who Fail Standard Meds May Have Another Option
THURSDAY, Dec. 8, 2022 (HealthDay News) — An experimental therapy that uses the body’s own immune system cells may beat a standard treatment for patients with advanced melanoma, a new clinical trial finds.Researchers found that the therapy doubled th…
Learn More2013 to 2017 Saw Significant Drop in U.S. Melanoma Mortality Rates
TUESDAY, Dec. 6, 2022 (HealthDay News) — The introduction of new melanoma treatments coincided with a reduction in the melanoma mortality rate (MMR) in the United States, according to a study published online Dec. 6 in JAMA Network Open.Navkirat Kahl…
Learn MoreMelanoma Diagnosis Linked to Increased Risk of Prostate Cancer
TUESDAY, Nov. 29, 2022 (HealthDay News) — Melanoma diagnosis is associated with increased risk of subsequent prostate cancer, according to a study published online Nov. 1 in the British Journal of Cancer.Sam Egger, from the University of Sydney, and …
Learn MoreQOL Up With Pembrolizumab Versus Ipilimumab, HDI in Resected Melanoma
MONDAY, Nov. 28, 2022 (HealthDay News) — For patients with high-risk resected melanoma, adjuvant pembrolizumab improves quality of life (QOL) compared with standard of care with ipilimumab or high-dose interferon α 2b (HDI), according to a study publ…
Learn MoreSubset of Stage I Melanoma Patients ID’d With Very Low Mortality
MONDAY, Nov. 7, 2022 (HealthDay News) — A subset of melanoma patients with stage I lesions and negative clinical nodes with very low risk for mortality from melanoma has been identified, according to a study published online Nov. 7 in Cancer.Megan M….
Learn More